ProShare Advisors
LLY icon

ProShare Advisors’s Eli Lilly LLY Stock Holding History

ProShare Advisors’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$115M Sell
125,546
-28,958
-19% -$29.4M 0.17% 119
2025
Q4 		$166M Buy
154,504
+10,876
+8% +$10.4M 0.29% 85
2025
Q3 		$110M Sell
143,628
-2,202
-2% -$1.64M 0.23% 118
2025
Q2 		$114M Buy
145,830
+16,805
+13% +$13.1M 0.23% 121
2025
Q1 		$107M Buy
129,025
+2,389
+2% +$1.99M 0.24% 117
2024
Q4 		$97.8M Buy
126,636
+14,685
+13% +$12.2M 0.22% 118
2024
Q3 		$99.2M Sell
111,951
-8,351
-7% -$7.51M 0.24% 107
2024
Q2 		$109M Buy
120,302
+8,246
+7% +$6.6M 0.29% 104
2024
Q1 		$87.2M Sell
112,056
-2,553
-2% -$1.82M 0.23% 109
2023
Q4 		$66.8M Sell
114,609
-10,571
-8% -$6.17M 0.2% 114
2023
Q3 		$67.2M Sell
125,180
-3,797
-3% -$1.96M 0.21% 113
2023
Q2 		$60.5M Buy
128,977
+3,196
+3% +$1.34M 0.18% 116
2023
Q1 		$43.2M Buy
125,781
+14,880
+13% +$5.02M 0.13% 145
2022
Q4 		$40.6M Buy
110,901
+121
+0.1% +$42.9K 0.14% 135
2022
Q3 		$35.8M Sell
110,780
-12,090
-10% -$3.83M 0.14% 137
2022
Q2 		$39.8M Sell
122,870
-47,416
-28% -$14.2M 0.13% 144
2022
Q1 		$48.8M Sell
170,286
-4,593
-3% -$1.18M 0.1% 173
2021
Q4 		$48.3M Buy
174,879
+38,876
+29% +$9.86M 0.09% 180
2021
Q3 		$31.4M Sell
136,003
-2,687
-2% -$663K 0.09% 179
2021
Q2 		$31.8M Buy
138,690
+22,361
+19% +$4.49M 0.09% 188
2021
Q1 		$21.7M Sell
116,329
-284
-0.2% -$55.6K 0.07% 217
2020
Q4 		$19.7M Buy
116,613
+3,033
+3% +$453K 0.07% 212
2020
Q3 		$16.8M Sell
113,580
-4,367
-4% -$676K 0.08% 196
2020
Q2 		$19.4M Buy
117,947
+26,694
+29% +$4.1M 0.1% 161
2020
Q1 		$12.7M Sell
91,253
-61,580
-40% -$8.46M 0.09% 174
2019
Q4 		$20.1M Buy
152,833
+29,567
+24% +$3.43M 0.09% 172
2019
Q3 		$13.8M Buy
123,266
+5,069
+4% +$564K 0.08% 219
2019
Q2 		$13.1M Sell
118,197
-22,278
-16% -$2.62M 0.08% 224
2019
Q1 		$18.2M Sell
140,475
-4,596
-3% -$559K 0.11% 159
2018
Q4 		$16.8M Buy
145,071
+4,662
+3% +$521K 0.12% 147
2018
Q3 		$15.1M Sell
140,409
-11,962
-8% -$1.2M 0.1% 165
2018
Q2 		$13M Sell
152,371
-39,971
-21% -$3.28M 0.09% 185
2018
Q1 		$14.9M Buy
192,342
+5,256
+3% +$423K 0.1% 176
2017
Q4 		$15.8M Buy
187,086
+48,313
+35% +$4.11M 0.11% 157
2017
Q3 		$11.9M Buy
138,773
+41,190
+42% +$3.38M 0.11% 160
2017
Q2 		$8.03M Sell
97,583
-266
-0.3% -$21.7K 0.08% 236
2017
Q1 		$8.23M Sell
97,849
-1,860
-2% -$149K 0.09% 217
2016
Q4 		$7.33M Buy
99,709
+19,199
+24% +$1.43M 0.08% 218
2016
Q3 		$6.46M Sell
80,510
-39,666
-33% -$3.17M 0.09% 178
2016
Q2 		$9.46M Buy
120,176
+2,080
+2% +$157K 0.12% 150
2016
Q1 		$8.5M Sell
118,096
-59,158
-33% -$4.48M 0.12% 164
2015
Q4 		$14.9M Buy
177,254
+9,231
+5% +$766K 0.18% 130
2015
Q3 		$14.1M Buy
168,023
+6,966
+4% +$588K 0.2% 123
2015
Q2 		$13.4M Sell
161,057
-24,854
-13% -$1.89M 0.19% 130
2015
Q1 		$13.5M Sell
185,911
-19,216
-9% -$1.37M 0.16% 146
2014
Q4 		$14.2M Buy
205,127
+32,164
+19% +$2.17M 0.16% 134
2014
Q3 		$11.2M Sell
172,963
-42,854
-20% -$2.71M 0.15% 121
2014
Q2 		$13.4M Sell
215,817
-13,455
-6% -$803K 0.17% 100
2014
Q1 		$13.5M Buy
229,272
+15,577
+7% +$869K 0.17% 97
2013
Q4 		$10.9M Buy
213,695
+113,258
+113% +$5.67M 0.16% 114
2013
Q3 		$5.05M Sell
100,437
-61,533
-38% -$3.22M 0.12% 133
2013
Q2 		$7.96M Buy
+161,970
New +$8.81M 0.16% 112

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

ProShare Advisors's LLY Position: Q1 2026 in Review

ProShare Advisors reduced its Eli Lilly (LLY) stake by 19% in Q1 2026, selling an estimated $29.4M and leaving 125,546 shares worth $115M. The position accounts for 0.17% of the portfolio, ranked #119.

ProShare Advisors first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $166M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • ProShare Advisors held 125,546 shares of Eli Lilly worth $115M as of Q1 2026.
  • ProShare Advisors sold 28,958 Eli Lilly shares in Q1 2026, an estimated $29.4M.
  • Eli Lilly made up 0.17% of ProShare Advisors's portfolio in Q1 2026, its #119 holding.
  • ProShare Advisors first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
  • ProShare Advisors's Eli Lilly position peaked at $166M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on ProShare Advisors's 13F filing for Q1 2026, filed 27 Apr 2026.